Buspirone Hydrochloride
Product Images NDC 53002-1425

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 53002-1425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

Chemical structure diagram of Buspirone Hydrochloride, showing its molecular composition including rings and functional groups connected in a specific arrangement.*

FDA Label Image

10 mg (one-third Of A Tablet) (Image 10)

Buspirone Hydrochloride tablet imprinted with the number '10'. The white, square-shaped tablet is shown against a plain background. No additional markings or packaging details are visible in the image.*

FDA Label Image

Break Tablet 30 mg (Image 11)

Buspirone Hydrochloride tablets imprinted with 10 on both sides, shown being held between two fingers. The image clearly shows the product as scored white tablets, each marked with the strength '10' on both sides of the score line, consistent with a 10 mg dosage form.*

FDA Label Image

15 mg (the Entire Tablet) (Image 2)

Buspirone Hydrochloride 5 mg white, oblong, scored tablet imprinted with 'TV 1003' on one side and '5 5 5' on the other. Manufactured by RPK Pharmaceuticals, Inc. The image shows the front and back of one tablet.*

FDA Label Image

10 mg (two-thirds Of A Tablet) (Image 3)

Buspirone Hydrochloride tablet imprinted with '5 5', indicating each tablet has a strength of 5 mg. The image shows the front of the tablet distinctly divided by a score line in the middle. The manufacturer is RPK Pharmaceuticals, Inc.*

FDA Label Image

7.5 mg (one-half Of A Tablet) (Image 4)

Buspirone Hydrochloride tablet with the imprint "5" indicating a 5 mg strength. The tablet is white, round, and scored, shown on a plain background. The image does not display the package or labeler information.*

FDA Label Image

5 mg (one-third Of A Tablet) (Image 5)

Buspirone Hydrochloride tablet with the imprint '5' visible, indicating a 5 mg strength. The image shows a single white, square-shaped tablet. The labeler of this product is RPK Pharmaceuticals, Inc.*

FDA Label Image

Break Tablet 15 mg (Image 6)

Buspirone Hydrochloride tablets, white and marked with the number '5' on one side, are shown held between fingers. The image focuses on the imprint indicating strength, consistent with 5 mg dosage. No packaging or additional labeling information is visible.*

FDA Label Image

30 mg (the Entire Tablet) (Image 7)

Buspirone Hydrochloride white, rectangular scored tablet with imprint 'TV' on one side and '5200' on the other, along with '10 10 10' on the reverse side. The image focuses on the tablet's markings and score line.*

FDA Label Image

20 mg (two-thirds Of A Tablet) (Image 8)

Buspirone Hydrochloride oral tablet blister pack with ten tablets per row, two rows visible, plain white tablets with the imprint '10 10' in two sections separated by a scored line. Labeler is RPK Pharmaceuticals, Inc. Product NDC 53002-1425.*

FDA Label Image

15 mg (one-half Of A Tablet) (Image 9)

Buspirone Hydrochloride tablet blister pack showing a single white tablet labeled with the number '10' embossed on one side. The labeler is RPK Pharmaceuticals, Inc.*

FDA Label Image

Label Image (Lbl530021425)

Buspirone Hydrochloride 30 mg tablets packaging label by RPK Pharmaceuticals, Inc., showing a carton with 30 tablets. The label includes directions for use stating to take tablets two times a day as directed by a prescriber. Additional details include lot number, expiration date, barcode, and space for clinic and prescriber information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.